The P-value of the Cox univariate regression analysis using different gene sets. (A) The P-values of the Cox univariate regression analysis for pathway-based genes (blue) and top mutated genes (orange). (B) The P-values of univariant test and multivariant test for pathway-based genes (blue and grey) and top mutated genes (orange and purple). (PDF 344Â kb
Figure S3. Survival analysis (Kaplan–Meier estimates) with breast cancer-specific survival (BCSS) as...
Figure S2. Survival analysis (KaplanâMeier estimates) with breast cancer-specific survival (BCSS) ...
Complete results of the random holdout analysis. The table contains the average HR and P values comp...
The KaplanâMeier estimator using top 35 mutated genes. The KaplanâMeier curves using 35 mutated ...
The comparison of mutation rates for top mutated genes and 14 pathway genes. The mutation rates for ...
The KaplanâMeier estimator for an independent patient dataset. The survival curve base on 64 of 11...
PATHER significantly enriched terms base on 118 survival related genes. (DOCX 15Â kb
Table S2. Effects of BRCA germline mutation and other prognostic factors (all covariates) on clinica...
Table S1. Multivariate Cox proportional hazards model analysis for Fig. 1b-h. (PDF 401 kb
Figure S1. Survival analysis (Kaplan–Meier estimates) with breast cancer-specific survival (BCSS) as...
Table S2. Multivariate Cox proportional hazards model analysis for Fig. 2a-f. (PDF 401 kb
Developed clinico-genomic model through the full biomarker-by-treatment interaction Cox model subjec...
Figure S1. Kaplan-Meier estimates of disease-free survival (A), freedom from breast cancer recurrenc...
Figure S4. Survival analysis (KaplanâMeier estimates) with breast cancer-specific survival (BCSS) ...
Figure S1. UPGMA dendrogram comparing the seven prediction scores for breast cancer (Panel A) and lu...
Figure S3. Survival analysis (Kaplan–Meier estimates) with breast cancer-specific survival (BCSS) as...
Figure S2. Survival analysis (KaplanâMeier estimates) with breast cancer-specific survival (BCSS) ...
Complete results of the random holdout analysis. The table contains the average HR and P values comp...
The KaplanâMeier estimator using top 35 mutated genes. The KaplanâMeier curves using 35 mutated ...
The comparison of mutation rates for top mutated genes and 14 pathway genes. The mutation rates for ...
The KaplanâMeier estimator for an independent patient dataset. The survival curve base on 64 of 11...
PATHER significantly enriched terms base on 118 survival related genes. (DOCX 15Â kb
Table S2. Effects of BRCA germline mutation and other prognostic factors (all covariates) on clinica...
Table S1. Multivariate Cox proportional hazards model analysis for Fig. 1b-h. (PDF 401 kb
Figure S1. Survival analysis (Kaplan–Meier estimates) with breast cancer-specific survival (BCSS) as...
Table S2. Multivariate Cox proportional hazards model analysis for Fig. 2a-f. (PDF 401 kb
Developed clinico-genomic model through the full biomarker-by-treatment interaction Cox model subjec...
Figure S1. Kaplan-Meier estimates of disease-free survival (A), freedom from breast cancer recurrenc...
Figure S4. Survival analysis (KaplanâMeier estimates) with breast cancer-specific survival (BCSS) ...
Figure S1. UPGMA dendrogram comparing the seven prediction scores for breast cancer (Panel A) and lu...
Figure S3. Survival analysis (Kaplan–Meier estimates) with breast cancer-specific survival (BCSS) as...
Figure S2. Survival analysis (KaplanâMeier estimates) with breast cancer-specific survival (BCSS) ...
Complete results of the random holdout analysis. The table contains the average HR and P values comp...